HR 1660 115th Congress

Global Health Innovation Act of 2017

Latest Action

Became Public Law No: 115-411.

Summary

Global Health Innovation Act of 2017 This bill directs the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities. Such reports shall include topics including: (1) USAID's health product development goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.

Global Health Innovation Act of 2017 (Sec. 2) This bill directs the Administrator of the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities. Such reports shall include descriptions of: (1) goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) Global Health Innovation Act of 2017 (Sec. 2) This bill directs the Administrator of the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities. Such reports shall include descriptions of: (1) goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.

Global Health Innovation Act of 2017 This bill directs the Administrator of the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.

Vote Result

Passed House

On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 34). (text: CR 1/17/2018 H439)

Actions

2019-01-03T00:00:00

Became Public Law No: 115-411.

2019-01-03T00:00:00

Became Public Law No: 115-411.

2019-01-03T00:00:00

Signed by President.

2019-01-03T00:00:00

Signed by President.

2018-12-27T00:00:00

Presented to President.

2018-12-27T00:00:00

Presented to President.

2018-12-21T00:00:00

Message on Senate action sent to the House.

2018-12-20T00:00:00

Passed Senate without amendment by Unanimous Consent. (consideration: CR S8002)

2018-12-20T00:00:00

Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S8002)

2018-03-22T00:00:00

Placed on Senate Legislative Calendar under General Orders. Calendar No. 364.

2018-03-22T00:00:00

Committee on Foreign Relations. Reported by Senator Corker without amendment. Without written report.

2018-03-22T00:00:00

Committee on Foreign Relations. Reported by Senator Corker without amendment. Without written report.

2018-03-20T00:00:00

Committee on Foreign Relations. Ordered to be reported without amendment favorably.

2018-01-19T00:00:00

Received in the Senate and Read twice and referred to the Committee on Foreign Relations.

2018-01-18T00:00:00

Motion to reconsider laid on the table Agreed to without objection.

2018-01-18T00:00:00

On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 34). (text: CR 1/17/2018 H439)

2018-01-18T00:00:00

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 34).(text: CR 1/17/2018 H439)

2018-01-18T00:00:00

Considered as unfinished business. (consideration: CR H538-539)

2018-01-17T00:00:00

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

2018-01-17T00:00:00

DEBATE - The House proceeded with forty minutes of debate on H.R. 1660.

2018-01-17T00:00:00

Considered under suspension of the rules. (consideration: CR H439-440)

2018-01-17T00:00:00

Mr. Royce (CA) moved to suspend the rules and pass the bill.

2017-09-28T00:00:00

Committee Consideration and Mark-up Session Held.

2017-09-28T00:00:00

Ordered to be Reported by Voice Vote.

2017-03-21T00:00:00

Referred to the House Committee on Foreign Affairs.

2017-03-21T00:00:00

Introduced in House

2017-03-21T00:00:00

Introduced in House

Policy Areas

International Affairs

Track this bill on CivicBeacon

Get push notifications when this bill is updated, contact your reps, and take action.

Global Health Innovation Act of 2017

Sponsors

Summary

Vote Result

Actions

Policy Areas

Track this bill on CivicBeacon